Medpace (NASDAQ: MEDP) director plans 3,858-share sale after option exercise
Rhea-AI Filing Summary
Medpace Holdings, Inc. (MEDP) received a notice under Rule 144 that director Robert O. Kraft plans to sell restricted common stock. The planned sale covers 3,858 shares of common stock through Fidelity Brokerage Services LLC on or about August 26, 2026, in connection with a stock option exercise. The shares are listed on NASDAQ. The notice is signed on Kraft’s behalf by Fidelity as attorney-in-fact.
Positive
- None.
Negative
- None.
Key Figures
Shares to be sold: 3,858 shares of common stock
Aggregate market value: 2,383,522.47
Shares outstanding: 27,911,655 shares
+1 more
4 metrics
Shares to be sold
3,858 shares of common stock
Planned Rule 144 sale related to stock option exercise
Aggregate market value
2,383,522.47
Aggregate market value of 3,858 shares to be sold
Shares outstanding
27,911,655 shares
Number of common shares outstanding referenced in the notice
Approximate sale date
08/26/2026
Planned date for Rule 144 sale
Key Terms
Rule 144, aggregate market value, stock option exercise, attorney-in-fact
4 terms
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
aggregate market value financial
"Common | Fidelity Brokerage Services LLC ... | 2383522.47 | 27911655 |"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
stock option exercise financial
"Common | 08/26/2026 | Stock Option Exercise | Issuer"
A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.
attorney-in-fact regulatory
"as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Robert O. Kraft"
An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.
FAQ
What does the Form 144 filing disclose for Medpace Holdings, Inc. (MEDP)?
The filing discloses that director Robert O. Kraft intends to sell 3,858 shares of Medpace Holdings, Inc. common stock under Rule 144, in connection with a stock option exercise, through Fidelity Brokerage Services LLC, with an expected sale date of August 26, 2026.
Who is executing the planned Form 144 sale for Medpace (MEDP) director Robert O. Kraft?
The planned sale will be executed through Fidelity Brokerage Services LLC. The Form 144 is signed by Daniel Tucci as a duly authorized representative of Fidelity, acting as attorney-in-fact for Robert O. Kraft.
AI-generated analysis. How Rhea-AI works. Not financial advice.